Document is current
Any future updates will be listed below
-
Authors
Schertzer, Megan D. https://orcid.org/0000-0003-4997-8221
Stirn, Andrew
Isaev, Keren
Pereira, Laura
Park, Stella H. https://orcid.org/0009-0008-0933-8602
Das, Anjali
Réal, Aline
Jeffery, Erin D. https://orcid.org/0000-0001-9511-7719
Harbison, Claire
Wessels, Hans-Hermann
Sheynkman, Gloria M. https://orcid.org/0000-0002-4223-9947
Sanjana, Neville E.
Knowles, David A. https://orcid.org/0000-0002-7408-146X
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (F32GM142213)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (DP2HG010099)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R21CA272345)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01AI176601)
- License Information
-
More Information
Article History
Received: 6 October 2023
Accepted: 10 July 2025
First Online: 29 July 2025
Competing interests
: G.M.S. is on the scientific advisory board of Quantum-Si Incorporated and holds stock in Quantum-Si Incorporated. N.E.S. is an adviser to Qiagen and a co-founder and adviser of TruEdit Bio and OverT Bio. The remaining authors declare no competing interests.
